Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma ‐associated antigen‐A3 expression through Yes‐associated protein inactivation

In conclusion, sitagliptin may have a potential inhibitory effect on GC by AMPK/YAP/melanoma‐associated antigen‐A3 pathway.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Tags: ORIGINAL RESEARCH Source Type: research